Published in Br J Cancer on January 01, 1981
An industry wide mortality study of chemical workers occupationally exposed to benzene. I. General results. Br J Ind Med (1987) 1.62
The toxicology of benzene. Environ Health Perspect (1993) 1.39
A retrospective mortality study among Canadian petroleum marketing and distribution workers. Environ Health Perspect (1993) 1.39
An epidemiological study of petroleum refinery employees. Br J Ind Med (1986) 1.31
Risk assessment of leukaemia and occupational exposure to benzene. Br J Ind Med (1989) 1.30
A 39-year follow-up of the U.K. oil refinery and distribution center studies: results for kidney cancer and leukemia. Environ Health Perspect (1993) 1.30
Epidemiological survey of oil distribution centres in Britain. Br J Ind Med (1983) 1.27
Incidence of leukaemia and lymphoma in young people in the vicinity of the petrochemical plant at Baglan Bay, South Wales, 1974 to 1991. Occup Environ Med (1995) 1.02
Epidemiological survey of maintenance workers in London Transport Executive bus garages and Chiswick Works. Br J Ind Med (1983) 0.87
State of the science on the carcinogenicity of gasoline with particular reference to cohort mortality study results. Environ Health Perspect (1993) 0.80
Estimation of multiple relative risk functions in matched case-control studies. Am J Epidemiol (1978) 4.76
Use of the logistic model in retrospective studies. Biometrics (1976) 4.07
Leukaemia in benzene workers. Lancet (1977) 3.55
Statistical analysis of patient-control studies in epidemiology. Factor under investigation an all-or-none variable. Br J Prev Soc Med (1970) 2.94
Leukemia in shoe-workers exposed chronically to benzene. Blood (1974) 2.52
BENZENE AND LEUKEMIA. N Engl J Med (1964) 2.44
Multivariate analysis for matched case-control studies. Am J Epidemiol (1978) 2.40
Synthetic retrospective studies and related topics. Biometrics (1973) 2.31
Long-term mortality study of steelworkers. VI. Mortality from malignant neoplasms among coke oven workers. J Occup Med (1972) 2.11
Confounding and effect-modification. Am J Epidemiol (1974) 2.01
Solvent exposure and leukemia among rubber workers: an epidemiologic study. J Occup Med (1975) 2.00
Benzene and leukemia. Environ Res (1976) 1.97
An epidemiological approach to the rubber industry. A study based on departmental experience. J Occup Med (1968) 1.79
Neoplasia and dysplasia of the cervix uteri and contraception: a possible protective effect of the diaphragm. Br J Cancer (1978) 1.68
Cancer mortality in oil refinery workers. J Occup Med (1979) 1.46
Mortality among workers employed in petroleum refining and petrochemical plants. J Occup Med (1980) 1.44
Evaluation of exposure to benzene vapour during the loading of petrol. Br J Ind Med (1972) 1.33
A mortality study of oil refinery workers. J Occup Med (1979) 1.30
Epidemiologic survey of leukemia in persons potentially exposed to benzene. J Occup Med (1974) 1.13
Service station attendants' exposure to benzene and gasoline vapors. Am Ind Hyg Assoc J (1979) 1.11
Acute leukemia due to chronic exposure to benzene. Am J Med (1972) 1.00
The use of logistic regression for modelling risk factors: with application to non-melanoma skin cancer. Am J Epidemiol (1978) 0.92
Occupational exposure of petrol pump workers. Ann Occup Hyg (1975) 0.91
Benzene in motor gasoline--an investigation into possible health hazards in and around filling stations and in normal transport operations. Ann Occup Hyg (1971) 0.88
Occupational hygiene in aromatics plants. Ann Occup Hyg (1971) 0.79
Simultaneous inference in epidemiological studies. Int J Epidemiol (1982) 5.77
Accuracy of diagnosis on death certificates compared with that in hospital records. Br J Prev Soc Med (1967) 4.17
Death certification. Br Med J (Clin Res Ed) (1983) 3.47
Fas and FasL in the homeostatic regulation of immune responses. Immunol Today (1995) 3.24
Relationship of passive smoking to risk of lung cancer and other smoking-associated diseases. Br J Cancer (1986) 3.21
The activation antigen CD69. Stem Cells (1994) 3.03
Interleukin 1 signaling occurs exclusively via the type I receptor. Proc Natl Acad Sci U S A (1993) 2.67
The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity (1994) 2.59
Self-poisoning--what is the future? Lancet (1974) 2.56
An epidemiological survey of eight oil refineries in Britain. Br J Ind Med (1981) 2.13
Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor. Cell (1993) 2.11
Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes. J Virol (1996) 2.07
Characterization of human CD8+ T cells reactive with Mycobacterium tuberculosis-infected antigen-presenting cells. J Exp Med (1998) 2.06
Molecular characterization and human T-cell responses to a member of a novel Mycobacterium tuberculosis mtb39 gene family. Infect Immun (1999) 1.95
The extracellular domain of the Epstein-Barr virus BZLF2 protein binds the HLA-DR beta chain and inhibits antigen presentation. J Virol (1996) 1.93
Private funding of elective hospital treatment in England and Wales, 1997-8: national survey. BMJ (2000) 1.90
Late complications of sterilisation by laparoscopy and tubal ligation. A controlled study. Lancet (1975) 1.89
The relative significance of prognostic factors in breast carcinoma. Br J Cancer (1971) 1.79
Scrotal cancer in the north-west of England, 1962-68. Br J Ind Med (1972) 1.77
T cell expression cloning of a Mycobacterium tuberculosis gene encoding a protective antigen associated with the early control of infection. J Immunol (2000) 1.76
A metalloprotease inhibitor blocks shedding of the IL-6 receptor and the p60 TNF receptor. J Immunol (1995) 1.70
Molecular and immunological characterization of Mycobacterium tuberculosis CFP-10, an immunodiagnostic antigen missing in Mycobacterium bovis BCG. J Clin Microbiol (2000) 1.66
Meta-analysis of mortality and cancer incidence among workers in the synthetic rubber-producing industry. Am J Epidemiol (2006) 1.64
Is occupational dermatitis being taken seriously by UK industries? Occup Med (Lond) (1999) 1.58
The use of family health services authority registers as a sampling frame in the UK: a review of theory and practice. J Epidemiol Community Health (1995) 1.58
Results from a lifestyle survey: Trent health. Health Educ Res (1994) 1.57
Cloning, expression, and immunological evaluation of two putative secreted serine protease antigens of Mycobacterium tuberculosis. Infect Immun (1999) 1.55
Validity of the British system for anticoagulant control using the national reagent. J Clin Pathol (1970) 1.54
Classically restricted human CD8+ T lymphocytes derived from Mycobacterium tuberculosis-infected cells: definition of antigenic specificity. J Immunol (2001) 1.54
Mortality in the UK industrial silica sand industry: 2. A retrospective cohort study. Occup Environ Med (2005) 1.53
Selective activation-induced apoptosis of peripheral T cells imposed by macrophages. A potential mechanism of antigen-specific peripheral lymphocyte deletion. J Immunol (1996) 1.52
gld/gld mice are unable to express a functional ligand for Fas. Eur J Immunol (1994) 1.50
Some sources of error in British occupational mortality data. Br J Ind Med (1972) 1.42
Clinical implications of white coat hypertension: an ambulatory blood pressure monitoring study. J Hum Hypertens (1999) 1.39
Molecular cloning and immunologic reactivity of a novel low molecular mass antigen of Mycobacterium tuberculosis. J Immunol (1998) 1.38
Are clinical trials required. Gerontol Clin (Basel) (1974) 1.38
Data on sickness absence in some recent publications of the Ministry of Pensions and National Insurance. Br J Prev Soc Med (1967) 1.36
Molecular characterization of the early activation antigen CD69: a type II membrane glycoprotein related to a family of natural killer cell activation antigens. Eur J Immunol (1993) 1.34
CD40 ligand is not essential for the development of cell-mediated immunity and resistance to Mycobacterium tuberculosis. J Immunol (1998) 1.33
Mycobacterium tuberculosis-reactive CD8+ T lymphocytes: the relative contribution of classical versus nonclassical HLA restriction. J Immunol (2000) 1.31
Molecular cloning, expression, and immunogenicity of MTB12, a novel low-molecular-weight antigen secreted by Mycobacterium tuberculosis. Infect Immun (1998) 1.28
CD40/CD40 ligand interactions are required for T cell-dependent production of interleukin-12 by mouse macrophages. Eur J Immunol (1996) 1.28
Epidemiological survey of oil distribution centres in Britain. Br J Ind Med (1983) 1.27
Herpesvirus saimiri open reading frame 14, a protein encoded by T lymphotropic herpesvirus, binds to MHC class II molecules and stimulates T cell proliferation. J Immunol (1996) 1.25
Death certification in cancer of the breast. Br Med J (Clin Res Ed) (1984) 1.25
Benzene in the environment: an assessment of the potential risks to the health of the population. Occup Environ Med (2001) 1.22
Patients and procedures in short-stay independent hospitals in England and Wales, 1997-1998. J Public Health Med (2000) 1.21
A study of space-time clustering in Hodgkin's disease in the Manchester region. Br J Prev Soc Med (1971) 1.20
Effect of long-term treatment with salmeterol on asthma control: a double blind, randomised crossover study. BMJ (1997) 1.20
Death from ischaemic heart-disease and malignancy in adult patients with coeliac disease. Lancet (1976) 1.19
Risks of lung cancer, chronic bronchitis, ischaemic heart disease, and stroke in relation to type of cigarette smoked. J Epidemiol Community Health (1985) 1.19
Human purified protein derivative-specific CD4+ T cells use both CD95-dependent and CD95-independent cytolytic mechanisms. J Immunol (1998) 1.19
CD40 ligand is a T cell growth factor. Eur J Immunol (1993) 1.19
Locally generated particulate pollution and respiratory symptoms in young children. Thorax (2006) 1.17
Effect of granulocyte-macrophage colony-stimulating factor and interleukin-3 on interleukin-8 production by human neutrophils and monocytes. Blood (1993) 1.17
Vaccination with the T cell antigen Mtb 8.4 protects against challenge with Mycobacterium tuberculosis. J Immunol (2001) 1.16
CD40L: a multi-functional ligand. Semin Immunol (1993) 1.14
Variability of diurnal changes in ambulatory blood pressure and nocturnal dipping status in untreated hypertensive and normotensive subjects. Am J Hypertens (2000) 1.14
Lifestyle surveys--the complete answer? J Epidemiol Community Health (1997) 1.13
Prospects for a better vaccine against tuberculosis. Tuberculosis (Edinb) (2003) 1.12
Radical versus modified radical mastectomy for breast cancer. Ann R Coll Surg Engl (1981) 1.10
Induction of macrophage inflammatory protein-1 beta gene expression in human monocytes by lipopolysaccharide and IL-7. J Immunol (1991) 1.09
Immunogenicity of Mycobacterium tuberculosis antigens in Mycobacterium bovis BCG-vaccinated and M. bovis-infected cattle. Infect Immun (2006) 1.07
Recombinant CD40 ligand exerts potent biologic effects on T cells. J Immunol (1994) 1.07
Investigation of mortality. Referral to hospital among a representative sample of adults who died. Proc R Soc Med (1966) 1.07
Prophylaxis in haemophilia: a double-blind controlled trial. Br J Haematol (1976) 1.07
CD40 ligand inhibits Fas/CD95-mediated apoptosis of human blood-derived dendritic cells. Eur J Immunol (1997) 1.05
National trends in self-poisoning in women. Lancet (1985) 1.01
Pilot study of revised stillbirth and neonatal death certificates. Arch Dis Child (1984) 1.01
Retrospective estimation of exposure to benzene in a leukaemia case-control study of petroleum marketing and distribution workers in the United Kingdom. Occup Environ Med (1997) 1.00
The prevalence of occupational dermatitis in the UK printing industry. Occup Environ Med (2002) 0.99
Cancer incidence in patients with psoriasis. Br J Cancer (1983) 0.98
Evaluation of health information systems. Br Med Bull (1974) 0.96
T-independent activation of single B cells: an orderly analysis of overlapping stages in the activation pathway. Immunol Rev (1987) 0.95
Epidemiology of Hodgkin's disease. J Chronic Dis (1972) 0.92
Reducing domestic exposure to environmental tobacco smoke: a review of attitudes and behaviours. J R Soc Promot Health (2003) 0.91
Single cell studies on the role of B-cell stimulatory factor 1 in B-cell activation. Proc Natl Acad Sci U S A (1987) 0.91
B-cell stimulation. Curr Opin Immunol (1995) 0.91
New conjugate vaccines for the prevention of pneumococcal disease in developing countries. Drugs Today (Barc) (2011) 0.90
Epidemiological survey of maintenance workers in London Transport Executive bus garages and Chiswick Works. Br J Ind Med (1983) 0.87
Mortality patterns in eight U. K. oil refineries. Ann N Y Acad Sci (1982) 0.85
Evaluation of Surgicel Nu-knit, Merocel and Vasolene gauze nasal packs: a randomized trial. Rhinology (1996) 0.85
Mortality in the UK industrial silica sand industry: 1. Assessment of exposure to respirable crystalline silica. Occup Environ Med (2005) 0.85
Terminal care in malignant disease. Br J Prev Soc Med (1970) 0.85
Mortality of workers on an isopropyl alcohol plant and two MEK dewaxing plants. Br J Ind Med (1980) 0.85
Ensuring comparability of benzene exposure estimates across three nested case-control studies in the petroleum industry in support of a pooled epidemiological analysis. Chem Biol Interact (2009) 0.83
Systematic review and meta-analysis of mortality in crop protection product manufacturing workers. Occup Environ Med (2009) 0.82
Health of workmen in the chromate-producing industry in Britain. Br J Ind Med (1981) 0.81
Identification of OX40 ligand and preliminary characterization of its activities on OX40 receptor. Circ Shock (1994) 0.81
Clinical examinations to validate self-completion questionnaires: dermatitis in the UK printing industry. Contact Dermatitis (2002) 0.81
Prostate cancer. Epidemiology. Recent Results Cancer Res (1981) 0.81
Long term follow-up of patients with menorrhagia treated by irradiation. Br J Radiol (1971) 0.80
Twenty-four hour ambulatory blood pressure: a sample from a normal British population. J Hum Hypertens (1998) 0.80
The effect of cationic microbicide exposure against Burkholderia cepacia complex (Bcc); the use of Burkholderia lata strain 383 as a model bacterium. J Appl Microbiol (2013) 0.80
Intervention development in occupational research: an example from the printing industry. Occup Environ Med (2006) 0.79
Impact of private funding on access to elective hospital treatment in the regions of England and Wales. National records survey. Eur J Public Health (2001) 0.79
Assessing exposures in the United Kingdom's Armed Forces--a review of systems that collect data useful for exposure assessment. J R Army Med Corps (2001) 0.78